Cerebral blood volume and apparent diffusion coefficient – Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma-Reference-Cited by-同舟云学术

Cerebral blood volume and apparent diffusion coefficient – Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma

Published:2019-10 Issue: Volume:405 Page:116433
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Petrova Lucie,Korfiatis Panagiotis,Petr Ondra,LaChance Daniel H.,Parney Ian,Buckner Jan C.,Erickson Bradley J.

Funder

European Regional Development Fund

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference53 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Individualized targeted therapy for glioblastoma: fact or fiction?;Weller;Cancer J. (Sudbury, Mass),2012

3. Maintenance therapy with tumor-treating fields plus Temozolomide vs Temozolomide alone for Glioblastoma: a randomized clinical trial;Stupp;Jama,2015

4. Nonsurgical treatment of recurrent glioblastoma;Gallego;Current Oncol (Toronto, Ont),2015

5. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert;N. Engl. J. Med.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting response to chemotherapy in brain tumor patients based on MRI features;Clinical Neurology and Neurosurgery;2024-09

2. Relative cerebral blood volume as response predictor in the treatment of recurrent glioblastoma with anti-angiogenic therapy;Clinical Neurology and Neurosurgery;2023-10

3. Prognostication of overall survival in patients with brain metastases using diffusion tensor imaging and dynamic susceptibility contrast-enhanced MRI;The British Journal of Radiology;2022-12-01

4. Predicting Survival in Patients with Brain Tumors: Current State-of-the-Art of AI Methods Applied to MRI;Diagnostics;2022-09-01

5. Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism;Cell Death & Disease;2022-06-30